CDC studies show vaccine protection wanes over time
One study assessed Pfizer and Moderna’s effectiveness over time against infections among nursing home residents, and found it dropped from 75% pre-Delta to 53% when Delta became dominant. The study didn’t differentiate between asymptomatic, symptomatic and severe infections.
Another study used data from 21 hospitals to estimate the effectiveness of Pfizer and Moderna mRNA vaccines against hospitalization over time. Among 1,129 patients who received two doses of a mRNA vaccine, vaccine effectiveness was 86% 2 to12 weeks after vaccination and 84% at 13 to 24 weeks.
The third study, using New York state data, found all three vaccines’ effectiveness against infection dropped from 92% in early May to 80% at the end of July, but the effectiveness against hospitalization remained relatively stable.
Data from the three reports in the CDC’s Morbidity and Mortality Weekly Report, helped convince the Biden administration to recommend booster shots to people eight months after receiving their second dose, despite no completed late-stage clinical trials assessing the safety, efficacy and immunogenicity of a third dose.
Oxford study shows vaccinated just as contagious as unvaxxed
As The Defender reported Thursday, a British public health study released Aug. 16, indicates vaccinated people with “breakthrough” infections could pose a significant infection risk to those who have not been vaccinated.
A study by University of Oxford scientists found people who contract the Delta variant after being fully vaccinated carry a similar amount of the virus as those who catch the disease and have not been vaccinated.
The study also found protection was greatest in those vaccinated who already had natural immunity through previous infection.
Based on more than 3 million nose and throat swabs, Oxford University researchers found that 90 days after a second shot of the Pfizer or Astrazeneca vaccine, efficacy in preventing infections had slipped to 75% and 61% respectively.
Those results were down from 85% and 68%, respectively, seen two weeks after a second dose, with the decline in efficacy more pronounced among those 35 years and older.
The study also showed that after two doses of the Pfizer vaccine, effectiveness was at least as great as protection afforded by natural infection — with greater initial effectiveness against new PCR-positives but faster declines in protection against high viral burden and symptomatic infection.
Researchers said there was no evidence effectiveness varied by dosing interval, but protection was higher among those vaccinated who already had natural immunity.
The survey, which has yet to be peer-reviewed before publication in a scientific journal, underscores concerns by scientists that the Delta variant can infect fully vaccinated people at a greater rate than previous variants, and that the vaccinated could more easily transmit it.
CHD sues Rutgers over COVID vaccine mandate
Children’s Health Defense (CHD) along with 18 students on Monday filed a lawsuit in federal court against Rutgers University, its board of governors, Rutgers President Jonathan Holloway and others over the university’s decision to mandate COVID vaccines for students attending school in the fall.
The lawsuit states that in a free society, “all people have the right to decide their own medical treatment — especially to decide what to inject into their bodies. And every person has the right to make that decision voluntarily, free from coercion by anyone, and to be fully informed of the benefits and especially the risks of that decision.”
The lawsuit alleges Rutgers’ policy is a violation of the right to informed consent and the right to refuse unwanted medical treatments.
The complaint also alleges the policy is a breach of contract because in January 2021, the university assured students COVID vaccines would not be required in order to attend school. Just two months later, Rutgers flip-flopped and issued new requirements for taking the shot prior to attending classes.
According to the plaintiffs, Rutgers is working with all three manufacturers — Pfizer, Moderna and J&J — to study and develop their vaccines in on-going clinical trials, and will benefit financially if more people are required to take the shots which, until fully licensed by the FDA, are defined by the FDA as experimental.
The Rutgers requirement also constitutes a denial of equal protection, as administration, faculty and staff are not required to take the vaccine. It also conflicts with federal and state law, as neither has enacted legislation requiring COVID vaccines for citizens.
165 days and counting, CDC ignores The Defender’s inquiries
According to the CDC website, “the CDC follows up on any report of death to request additional information and learn more about what occurred and to determine whether the death was a result of the vaccine or unrelated.”
On March 8, The Defender contacted the CDC with a written list of questions about reported deaths and injuries related to COVID vaccines. We have made repeated attempts, by phone and email, to obtain a response to our questions.
Despite multiple phone and email communications with many people at the CDC, and despite being told that our request was in the system and that someone would respond, we have not yet received answers to any of the questions we submitted. It has been 165 days since we sent our first email to the CDC requesting information.